“…A growing body of research demonstrates benefits in clinical outcomes, patient satisfaction, health care utilization, and cost for palliative care for patients with serious illness, including urologic cancers, regardless of prognosis [3][4][5][6][7][8]. In response to this persuasive research, the American Society for Clinical Oncology has called for palliative care consultation for all patients with cancer with metastatic disease or high symptom burden or both [2], and palliative care is recognized as integral to routine oncology care by the National Comprehensive Cancer Network and the Commission on Cancer.…”